nalbuphine - CISMeF

Preferred Label : nalbuphine;

MeSH definition : A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.; A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS and an antagonist or partial agonist at MU RECEPTORS.;

CISMeF synonym : 23277-43-2 (Nalbuphine hydrochloride); SERB brand of nalbuphine; nalbuphine SERB brand; serb, nalbuphine; hydrochloride, nalbuphine; nalbuphine serb;

MeSH hyponym : Nalbuphine Hydrochloride; nubain; EN-2234A; EN 2234A; EN2234A;

MeSH CAS label : Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5alpha,6alpha)-;

MeSH Related Number : nalbuphine hydrochloride; 20594-83-6 (Nalbuphine); 23277-43-2 (HCl); ZU4275277R;

Registry Number MeSH : 20594-83-6;

Related CAS MeSH : ZU4275277R (Nalbuphine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Nalbuphine hydrochloride;

Codes EINECS : 243-901-6;

Is substance : O;

UNII : L2T84IQI2K;

InChIKey : NETZHAKZCGBWSS-CEDHKZHLSA-N;

Details

Origin ID

D009266;

UMLS CUI

C0027348;

ATC code(s)
- nalbuphine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Nalbuphine Hydrochloride [NCIt concept]
- Nalbuphine hydrochloride (product) [Inactive SNOMED CT concept]
- Nalbuphine hydrochloride (substance) [SNOMED CT concept]
- nalbuphine hydrochloride [SNOMED Notion]
CISMeF manual mappings
- Nalbuphine poisoning (disorder) [SNOMED CT concept]
- nalbuphine [Substance BNPC]
Currated CISMeF NLP mapping
- Nalbuphine [ICD-11 Extension code]
- Nalbuphine [LOINC component]
- Nalbuphine [ICHI extension code]
- Nalbuphine [SMS substance]
- Nalbuphine [NCIt concept]
- Nalbuphine (substance) [SNOMED CT concept]
- nalbuphine [SNOMED Notion]
Pharmacological action(s)
- analgesics, opioid [MeSH Descriptor]
- narcotic antagonists [MeSH Descriptor]
Record concept(s)
- EN-2234A [MeSH concept]
- Nalbuphine Hydrochloride [MeSH concept]
- Nalbuphine Serb [MeSH concept]
- nalbuphine [MeSH concept]
- nubain [MeSH concept]
Related MeSH Supplementary Concept(s)
- nalbuphine 3-acetylsalicylate [MeSH Supplementary Concept]
- nalbuphine pivalate [MeSH Supplementary Concept]
- sebacoyl dinalbuphine ester [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nalbuphine [LOINC component]
- Nalbuphine [ICD-11 Extension code]
- Nalbuphine [NCIt concept]
- Nalbuphine (substance) [SNOMED CT concept]
- Product containing nalbuphine (medicinal product) [SNOMED CT concept]
- nalbuphine [ATC Code]
- nalbuphine [Substance BNPC]
- nalbuphine [SNOMED Notion]
Validated automatic mappings to BTNT
- (5.ALPHA.,6.ALPHA.)-17-(CYCLOBUTYLMETHYL)-4,5-EPOXYMORPHINAN-3,6,14-TRIOL HYDROCHLORIDE [Substance BNPC]
- Nalbuphine Hydrochloride [NCIt concept]
- Nalbuphine hydrochloride [SMS substance]
- Nalbuphine hydrochloride (product) [Inactive SNOMED CT concept]
- Nalbuphine hydrochloride (substance) [SNOMED CT concept]
- nalbuphine [ATC Code]
- nalbuphine hydrochloride [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients